Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
EMA provides public access to clinical reports
As of today, the European Medicines Agency (EMA) gives open access to clinical reports for new medicines for human use authorised in the European Union (EU).
Is tuberculosis an autoimmune disease?
While the rate of tuberculosis in the United States has fallen over the past 20 years, worldwide, it remains a leading cause of death.
Teva Announces FDA Acceptance of Resubmitted New Drug Application for SD-809 for Treatment of Chorea Associated with Huntington Disease
JERUSALEM, Israel I October 20, 2016 I Teva Pharmaceutical Industries Ltd.
GSK exits U.S. market with its HPV vaccine Cervarix
Facing “very low market demand,” GlaxoSmithKline has decided to pull out of the U.
Treatment approach used in cancer holds promise for Alzheimer’s disease
Researchers hope this new treatment could be administered as simple nasal spray.
Can Keytruda beat Opdivo to full UK access in lung cancer?
Last week’s NICE rejection of Opdivo for routine use in lung cancer patients has presented BMS with another setback – and an opportunity for Merck Sharp & Dohme (Merck in the US) and i...
Merck's antiviral drug meets main goal in late-stage trial
Merck & Co Inc said its experimental drug to prevent cytomegalovirus infection in high-risk bone marrow transplant patients met its primary goal in a late-stage trial.
Canadian Ebola vaccine enters new trial phase
OTTAWA, Canada I October 18, 2016 I Today, the Honourable Marie-Claude Bibeau, Minister of International Development and La Francophonie, together with the Honourable Jane Philpott, Minister of Health...
ADC Therapeutics Announces Closing of $105 Million Private Financing
LAUSANNE, Switzerland I October 18, 2016 I ADC Therapeutics (ADCT), an oncology drug discovery and development company that specializes in the development of proprietary Antibody Drug Conjugat...
Colombian pharmaceutical market to see strong market growth, surpassing $7 billion by 2020, says GlobalData
The pharmaceutical market in Colombia is set to rise from $5 billion in 2015 to $7.
New molecule may help fight obesity
Researchers, including one of Indian-origin, have identified a new molecule that may help fight obesity and other metabolic diseases by converting 'bad' fat to 'good' fat.
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox® for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
JERUSALEM, Israel I October 17, 2016 I Teva Pharmaceutical Industries Ltd.
596
597
598
599
600
601
602
603
604
